Farrell C. Tyson

OCTANe connects people and ideas with capital and resources for technology growth in Orange County. It stimulates technology job growth and wealth creation; helps entrepreneurs turn ideas into successful businesses; helps companies connect with funding and growth resources; helps senior executives access intelligence, new technologies, and talent; helps develop technology business leaders; and creates a forum for technology company leaders to have an impact on the future. The company offers LaunchPad, a pro-bono accelerator for startup companies in the technology, life science, and clean tech industries. The company was founded in 2002 and is headquartered in Aliso Viejo, CA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

IanTech, Inc. develops ophthalmic devices for cataract surgery. Its products include miLoop, miPhaco, miMissions, and miResources. The company was founded by Luke Clauson and Sean Ianchulev and is headquartered in Reno, NV.

Equinox Ophthalmic, Inc. operates as a biotechnology company. It specializes in cataract, corneal and glaucoma surgery. The company was founded by John Berdahl and is headquartered in Sioux Falls, SD.

Flying L Management LLC (Flying L Management) is a venture capital firm founded in 2016. The firm is headquartered in Newport beach, California.

Surface Ophthalmics, Inc. operates as a biopharmaceutical company. It focuses on development and commercialization of innovative therapeutics. The firm’s current drug pipeline consists of three proprietary drug candidates. Surface topical eye drop drug candidates, SURF-100 and SURF-200, utilize a patented delivery vehicle. The company is founded by Mark L. Baum and it is headquartered in San Diego, CA.

The International Intra-Ocular Implant Club is a research organization that focuses on the field of intraocular lens implantation.

eyeonics, Inc. designs, develops, manufactures and sells premium intraocular lenses. Its lenses are implantable devices that replace the natural lens in the human eye, typically after the natural lens has developed cataracts that can significantly impair vision. The firm's products are designed to both replace a cataractous lens and correct a refractive error. The company was founded by Andrew J. Corley and Stuart J. Cumming in 1998 and is headquartered in Aliso Viejo, CA.

AcuFocus, Inc. develops KAMRA inlay for the treatment of presbyopia. Its KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. The company was founded in 2001 and is headquartered in Irvine, CA.

HighLife SAS develops percutaneous mitral valve replacement therapies. It offers a minimally invasive prosthetic mitral valve that is implanted on a beating heart, while preserving the native valve structure and respecting the surrounding anatomy. The company was founded by Georg Börtle in 2010 and is headquartered in Paris, France.

Sectoral Asset Management Inc (Private Equity) (Sectoral Asset Management) is a private equity subsidiary of Sectoral Asset Management, Inc. founded in 2008 by Michael Sjöström. The firm is headquartered in Montréal, Quebec.

Cagent Vascular LLC engages in manufacturing medical instruments. The company was founded by Carol Burns, Robert Giasolli and Peter Schneider and is headquartered in Wayne, PA.

Neuros Medical, Inc. develops neurostimulation therapies. It offers Altius System that consists of an implantable generator with an integrated rechargeable battery, cuff electrode, and external devices. The company was founded by Jon J. Snyder, Kevin L. Kilgore, and Niloy Bhadra in 2008 and is headquartered in Willoughby Hills, OH.

CurvaFix, Inc. operates as an emerging medical device company. It develops novel solution for an unmet need in orthopedic trauma. The company is headquartered in Bellevue, WA.

Tullis Health Investor Inc (Tullis Health) is a private equity and venture capital firm founded in 1986 by Jim Tullis. The firm is headquartered in Palm Beach, Florida.

Transcend Medical, Inc. operates as a medical device company. It develops medical devices for the treatment of glaucoma, the cause of adult irreversible blindness. The company was founded in 2005 and is headquartered in Lake Forest, CA.

Kurobe Pharmaceuticals, Inc. manufactures pharmaceuticals.

Part of Medtronic Plc, Medtronic Canada ULC is a leading Canadian healthcare technology company that aims to alleviate pain, restore health, and extend life by providing innovative technologies and therapies. With a team of over 90,000 passionate people, they address 70 health conditions, including cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Medtronic Canada ULC has been proudly serving Canadian healthcare for over 50 years and is headquartered in Brampton, Ontario, with regional offices in Vancouver. The company's mission is to transform the lives of two people every second, every hour, every day, by engineering the extraordinary.

Technolas Perfect Vision GmbH develops and markets laser and surgical technology solutions. Its brands include TENEO 317 Laser, VICTUS Femtosecond Laser, ZYOPTIX Diagnostic Workstation, and ZYOPTIX Microkeratome. The company was founded in 2009 and is headquartered in Munich, Germany.

AqueSys, Inc. is a clinical-stage medical device company that develops ocular implants that reduce intraocular pressure (IOP) associated with glaucoma. It focuses on commercializing implantable devices that will significantly improve the treatment of glaucoma. The company was founded by Charles E. Larsen in 2006 and is headquartered in Parsippany, NJ

ForSight VISION5, Inc. develops ocular drug delivery technologies and device solutions for ophthalmic diseases. It engages in the development of non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. Its lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to continually receive their medication. The company was founded by Eugene de Juan Jr., J. Andrew Corley and K. Angela Macfarlane in 2010 and is headquartered in Madison, NJ.

Neurolens, Inc. is a company that commercializes breakthrough technology to improve vision care. The company's patented contoured prism technology provides visual comfort for the nearly 65% of US adults who complain of headaches, neck/shoulder pain, and eyestrain when using digital devices, reading, or doing detail work. The company is based in Coppell, TX. Inspired by a breakthrough discovery linking optometry and neurology, Neurolens is unlocking a new dimension of vision care. The Neurolens contoured prism design helps the eyes work together comfortably, bringing the eyes into alignment to relieve painful symptoms. The technology is only available to independent eye care providers. The company was founded in 2012 by Davis Corley, and Pierre Bertrand has been the CEO of the company since 2019.

Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY.

Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN.

BELKIN Vision Ltd. provides glaucoma laser treatment. The company was founded by Michael Belkin in 2013 and is headquartered in Tel Aviv, Israel.

ReVision Optics, Inc. develops optical solutions for the treatment of presbyopia. The company also develops Raindrop Near Vision Corneal Inlay, which is a refractive surgery solution. ReVision Optics was founded by Hansen A. Yuan, Adrian Koppes and Alok Nigam in 1996 and is headquartered Lake Forest, CA.

Sectoral Asset Management, Inc. (Sectoral) is an investment management firm headquartered in Montréal, Canada. The firm was founded in 2000 by Jérôme G. Pfund and Michael J. Sjöström. They are a wholly-owned subsidiary of Sectoral Asset Management Holding Ltd. in Hong Kong. Sectoral manages public and private equity healthcare strategies for investors around the world. Their clients include sovereign wealth funds, private banks, and family offices. In addition, they have long-standing sub-advisory relationships with institutional investors in Europe and Asia.

AEye Technologies, Inc. engages in the development of vision hardware, software and algorithms that act as the eyes and visual cortex of autonomous vehicles. It specializes in computer vision, autonomous driving, robotic vision, autonomous vehicles, lidar, sensor fusion, and three dimensional mapping. The company was founded by Luis Dussan, Ranson Wuller, Barry Behnken, and Jordan Greene in 2013 and is headquartered in Dublin, CA.

AEYE Health LLC is a digital health company that provides fully autonomous, AI-based diagnostic screening solutions for retinal imaging with results. The company is based in New York, NY. The company aims to make diagnostic screening practical, accurate, and accessible. Its screening solution for diabetic retinopathy is FDA-cleared and designed to allow primary care providers to perform diabetic eye exams in their clinics instead of referring to specialists. AEYE Health enables point-of-care screening for diabetic retinopathy to ensure that patients with diabetes are regularly screened for diabetic retinopathy. The company's comprehensive screening utilizes AI technology to diagnose or predict the development of a broad range of diseases from retinal images. The team consists of machine learning experts and leaders in ophthalmology and innovation. The company was founded by Zack Dvey-Aharon, Danny Margalit. Zack Dvey-Aharon has been the CEO since incorporation.